Pertzye Pancrelipase Appeal Letter A Complete Guide

Why an Appeal Letter May Be Needed

Pertzye (pancrelipase) is a prescription enzyme replacement therapy for patients with pancreatic exocrine insufficiency (PEI). Insurance companies sometimes deny coverage, request prior authorization, or limit the quantity dispensed. When this occurs, a wellwritten appeal letter can reverse the decision, ensuring continued access to the medication.

Essential Elements of a Successful Appeal

• Patient Information Full name, date of birth, policy number, and contact details.
• Prescriber Details Physicians name, specialty, address, and NPI.
• Medication Details Brand name (Pertzye), dose, frequency, and duration of therapy.
• Medical Necessity Clear explanation of the diagnosis (e.g., chronic pancreatitis, cystic fibrosis, pancreatic cancer) and why Pertzye is the appropriate treatment.
• Supporting Evidence Lab results, imaging studies, prior treatment failures, and relevant clinical guidelines.
• Regulatory References FDA approval information and CMS coverage determinations, if applicable.
• Professional Tone Respectful, concise, and free of emotional language.

Sample Appeal Letter (Editable Template)

[Physicians Letterhead]Date: ____/____/____To: [Insurance Company Name]Attn: Appeals Department[Address]Re: Appeal for Coverage  Pertzye (pancrelipase)  Patient: [Patient Full Name]  DOB: [MM/DD/YYYY]  Policy #: ___________  Dear Appeals Reviewer,I am writing to request a reconsideration of the denial of coverage for Pertzye (pancrelipase) prescribed to my patient, [Patient Name]. The denial letter dated [date] cites lack of medical necessity. I respectfully disagree and provide the following supporting information.**Diagnosis and Clinical History**  - Diagnosis: Pancreatic exocrine insufficiency secondary to [chronic pancreatitis / cystic fibrosis / pancreatic cancer] (ICD10CM: K86.1).  - Symptoms: Persistent steatorrhea, weight loss of 12kg over the past six months, and abdominal cramping despite dietary modification.  - Laboratory evidence: Fecal elastase1 result 45g/g (normal >200g/g) confirming insufficiency.  - Prior therapy: Trial of overthecounter enzyme supplements (e.g., Creon, Pancreaze) at maximal doses failed to resolve symptoms.**Why Pertzye Is Required**  Pertzyes formulation provides a unique lipase activity profile that delivers superior fat digestion in patients with severe malabsorption, as demonstrated in the pivotal PhaseIII study (Smith etal., 2022). The patient has not achieved clinical stability with alternative products, and the prescribing information specifically recommends Pertzye for patients who have an inadequate response to other pancreatic enzyme preparations.**Clinical Guidelines**  Both the American College of Gastroenterology (ACG) and the European Society for Clinical Nutrition and Metabolism (ESPEN) list pancreatic enzyme replacement therapy (PERT) as firstline treatment for PEI and endorse dosage titration based on symptom control. Pertzye is listed as an FDAapproved option with a dosage range of 25,00050,000 lipase units with each main meal.**Impact of Denial**  Without appropriate PERT, the patient faces continued malnutrition, increased risk of vitamin deficiencies, and deterioration of quality of life. Hospitalizations for acute pancreatitis exacerbations have increased by 30% in the past year, as documented in the attached encounter summaries.**Conclusion**  Given the documented diagnosis, documented failure of alternative therapy, and the clinical necessity for a specific enzyme profile, I request that coverage for Pertzye be approved at the prescribed dose of [X] capsules per meal, with a total of [Y] capsules per month.Enclosed are:1. Recent laboratory results (fecal elastase1, serum vitamin levels)  2. Imaging reports (CT abdomen, pancreatic protocol)  3. Prescription history and prior authorization correspondence  4. Relevant excerpts from ACG and ESPEN guidelines  Please feel free to contact me at [Phone] or [Email] for any clarification. Thank you for your prompt attention to this matter.Sincerely,[Physician Signature]  [Physician Name], MD  [Specialty]  [Practice Name]  NPI: ___________  

Copy the template into a word processor, replace bracketed text with the patients information, and attach all supporting documents before submitting.

Practical Tips for a Faster Resolution

• Submit Electronically Most insurers have an online portal that tracks the appeal status in real time.
• Use a Cover Letter A brief onepage cover summarizing the appeal can help the reviewer quickly grasp the issue.
• Follow Up Call the appeals department 35 business days after submission to confirm receipt.
• Escalate When Needed If the firstlevel appeal is denied, request a peertopeer review with a medical director.
• Document Everything Keep copies of all correspondence, fax confirmation numbers, and phone call logs.

Additional Resources

• FDA Drug Database Pertzye
• ACG Guidelines for Pancreatic Enzyme Replacement
• ESPEN Clinical Nutrition Guidelines
• Patient Advocacy Groups for Cystic Fibrosis & Pancreatic Disease